BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 7988467)

  • 1. Pituitary adenylate cyclase-activating polypeptide stimulates both adrenocortical cells and chromaffin cells in the frog adrenal gland.
    Yon L; Chartrel N; Feuilloley M; De Marchis S; Fournier A; De Rijk E; Pelletier G; Roubos E; Vaudry H
    Endocrinology; 1994 Dec; 135(6):2749-58. PubMed ID: 7988467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for the involvement of chromaffin cells in the stimulatory effect of tachykinins on corticosteroid secretion by the frog adrenal gland.
    Kodjo MK; Leboulenger F; Porcedda P; Lamacz M; Conlon JM; Pelletier G; Vaudry H
    Endocrinology; 1995 Aug; 136(8):3253-9. PubMed ID: 7628358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ca(2+)-dependent stimulatory effect of pituitary adenylate cyclase-activating polypeptide on catecholamine secretion from cultured porcine adrenal medullary chromaffin cells.
    Isobe K; Nakai T; Takuwa Y
    Endocrinology; 1993 Apr; 132(4):1757-65. PubMed ID: 8384995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of the endozepine triakontatetraneuropeptide on corticosteroid secretion by the frog adrenal gland is mediated by activation of adenylyl cyclase and calcium influx through T-type calcium channels.
    Lesouhaitier O; Kodjo MK; Cartier F; Contesse V; Yon L; Delarue C; Vaudry H
    Endocrinology; 2000 Jan; 141(1):197-207. PubMed ID: 10614640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel splice variants of type I pituitary adenylate cyclase-activating polypeptide receptor in frog exhibit altered adenylate cyclase stimulation and differential relative abundance.
    Alexandre D; Vaudry H; Grumolato L; Turquier V; Fournier A; Jégou S; Anouar Y
    Endocrinology; 2002 Jul; 143(7):2680-92. PubMed ID: 12072402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors: distribution and involvement in the secretion of Podarcis sicula adrenal gland.
    Valiante S; Prisco M; Sciarrillo R; De Falco M; Capaldo A; Gay F; Andreuccetti P; Laforgia V; Varano L
    J Endocrinol; 2008 Feb; 196(2):291-303. PubMed ID: 18252952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced cAMP production mediates the stimulatory action of pituitary adenylate cyclase activating polypeptide (PACAP) on in vitro catecholamine secretion from bovine adrenal chromaffin cells.
    Perrin D; Germeshausen A; Söling HD; Wuttke W; Jarry H
    Exp Clin Endocrinol Diabetes; 1995; 103(2):81-7. PubMed ID: 7553079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary adenylate cyclase-activating polypeptide causes rapid Ca2+ release from intracellular stores and long lasting Ca2+ influx mediated by Na+ influx-dependent membrane depolarization in bovine adrenal chromaffin cells.
    Tanaka K; Shibuya I; Nagamoto T; Yamashita H; Kanno T
    Endocrinology; 1996 Mar; 137(3):956-66. PubMed ID: 8603609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAC1 receptor activation by PACAP-38 mediates Ca2+ release from a cAMP-dependent pool in human fetal adrenal gland chromaffin cells.
    Payet MD; Bilodeau L; Breault L; Fournier A; Yon L; Vaudry H; Gallo-Payet N
    J Biol Chem; 2003 Jan; 278(3):1663-70. PubMed ID: 12429744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypophysiotropic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: immunohistochemical demonstration of PACAP in the pituitary, PACAP stimulation of growth hormone release from pituitary cells, and molecular cloning of pituitary type I PACAP receptor.
    Wong AO; Leung MY; Shea WL; Tse LY; Chang JP; Chow BK
    Endocrinology; 1998 Aug; 139(8):3465-79. PubMed ID: 9681497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary adenylate cyclase-activating polypeptide and its receptors in amphibians.
    Yon L; Alexandre D; Montéro M; Chartrel N; Jeandel L; Vallarino M; Conlon JM; Kikuyama S; Fournier A; Gracia-Navarro F; Roubos E; Chow B; Arimura A; Anouar Y; Vaudry H
    Microsc Res Tech; 2001 Aug; 54(3):137-57. PubMed ID: 11458398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of vasotocin-like immunoreactivity in chromaffin cells of the frog adrenal gland: effect of vasotocin on corticosteroid secretion.
    Larcher A; Delarue C; Idres S; Lefebvre H; Feuilloley M; Vandesande F; Pelletier G; Vaudry H
    Endocrinology; 1989 Nov; 125(5):2691-700. PubMed ID: 2676489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pituitary adenylate cyclase-activating polypeptide regulates both adrenocortical and chromaffin cell activity in the frog adrenal gland.
    Yon L; Chartrel N; Montero M; Bellancourt G; Feuilloley M; Pelletier G; Roubos E; Arimura A; Conlon JM; Fournier A; Vaudry H
    Ann N Y Acad Sci; 1996 Dec; 805():697-701. PubMed ID: 8993463
    [No Abstract]   [Full Text] [Related]  

  • 14. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
    Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary adenylate cyclase-activating polypeptide causes Ca2+ release from ryanodine/caffeine stores through a novel pathway independent of both inositol trisphosphates and cyclic AMP in bovine adrenal medullary cells.
    Tanaka K; Shibuya I; Uezono Y; Ueta Y; Toyohira Y; Yanagihara N; Izumi F; Kanno T; Yamashita H
    J Neurochem; 1998 Apr; 70(4):1652-61. PubMed ID: 9523583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization, characterization and activity of pituitary adenylate cyclase-activating polypeptide in the frog adrenal gland.
    Yon L; Feuilloley M; Chartrel N; Arimura A; Fournier A; Vaudry H
    J Endocrinol; 1993 Nov; 139(2):183-94. PubMed ID: 8308455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and function of vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide, and their receptors in the human adrenal gland.
    Mazzocchi G; Malendowicz LK; Rebuffat P; Gottardo L; Nussdorfer GG
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2575-80. PubMed ID: 12050216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.
    Mazzocchi G; Malendowicz LK; Neri G; Andreis PG; Ziolkowska A; Gottardo L; Nowak KW; Nussdorfer GG
    Int J Mol Med; 2002 Mar; 9(3):233-43. PubMed ID: 11836629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization, characterization, and second messenger coupling of pituitary adenylate cyclase-activating polypeptide receptors in the fetal human adrenal gland during the second trimester of gestation.
    Yon L; Breault L; Contesse V; Bellancourt G; Delarue C; Fournier A; Lehoux JG; Vaudry H; Gallo-Payet N
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1299-305. PubMed ID: 9543159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary adenylate cyclase activating polypeptide provokes cultured rat chromaffin cells to secrete adrenaline.
    Watanabe T; Masuo Y; Matsumoto H; Suzuki N; Ohtaki T; Masuda Y; Kitada C; Tsuda M; Fujino M
    Biochem Biophys Res Commun; 1992 Jan; 182(1):403-11. PubMed ID: 1310018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.